Evoke Wealth, LLC Viatris Inc Transaction History

Evoke Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$8.48 - $11.13 $3,680 - $4,830	-434 Reduced 27.14%	1,165 $10,000
Q2 2022 Aug 04, 2022	BUY	$9.95 - $12.27 $3,323 - $4,098	334 Added 26.4%	1,599 $17,000
Q1 2022 May 10, 2022	SELL	$9.81 - $15.4 $166 - $261	-17 Reduced 1.33%	1,265 $14,000
Q4 2021 Feb 09, 2022	BUY	$12.09 - $14.68 $12 - $14	1 Added 0.08%	1,282 $17,000
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $4,902 - $5,598	-370 Reduced 22.41%	1,281 $17,000
Q2 2021 Aug 05, 2021	SELL	$12.97 - $16.15 $6,497 - $8,091	-501 Reduced 23.28%	1,651 $24,000
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $3,506 - $4,783	258 Added 13.62%	2,152 $30,000
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $27,084 - $35,493	1,894 New	1,894 $35,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.